Tufts Clinical and Translational Research Institute

申请我们的第二个CTSA，塔夫茨临床和转化科学研究所（CTSl）仍然热切 致力于全方位的临床和转化研究（CTR），以满足 生物医学科学，不仅仅是从工作台到床边（T1”）的翻译，对健康影响至关重要，翻译 有效的临床实践（“T2”）、护理提供和公共卫生（“TS”）以及卫生政策（“T4”）。2008年 我们在先前的CTR资源、服务和教育计划的基础上开始了塔夫茨CTSl，我们故意 选定的合作伙伴将利用和补充彼此的特殊资产。我们的38个战略- 选择的合作伙伴包括12个塔夫茨大学学校/研究中心，10个塔夫茨医院，3个学术 机构（布兰迪斯大学，东北大学，兰德公司），八个社区为基础的 组织，和五个行业合作伙伴，一个优秀的和协同的资源，机会， T1-T4频谱的教育。在我们的应用程序的四个部分中描述了四个目标， 该平台：目标1：通过以下方式全面加强塔夫茨CTSl：1）组织和领导其合作伙伴， 致力于共同技术合作伙伴这一共同家园; 2）扩大所有合作伙伴有效获得全方位的 以促进跨学科和机构合作CTR的方式提供高质量的资源 通过地方和国家的领导和新方法的开发来推进CTR领域;4） 在整个T1-4层提供创新和有特色的教育和培训。（第一节）AIM 2： 运营和实施CTR之家及其基础设施、服务和方案，包括其 中央办公室人事、行政和财务管理系统、委员会等 必要的结构。目标3：维持和发展创新资源、服务和政策， 支持和促进合作，跨学科，全方位的转化研究。（第三节） 4：通过T1-T4范围内的教育和培训，发展和扩大CTR劳动力， 特别关注解决从实验室到床边以及从床边到广泛应用之间的转换差距 对健康的影响（第四节） 相关性（见说明）： 塔夫茨临床和转化科学研究所使用的临床和转化的整个频谱 研究（CTR），以帮助满足生物医学科学的承诺和公众的需求。这包括板凳 “到床边（“TI”）的转化，并且对于具有健康影响至关重要的是，转化为有效的临床实践 （“T2”）、护理提供和公共卫生（“TS-”）以及卫生政策（“T4”）。

Applying for our second CTSA, Tufts Clinical and Translational Science Institute (CTSl) remains avidly committed to involving the full spectrum of clinical ahd translational research (CTR) to meet the pnsmise of biomedical science, not only bench to bedside (T1") translation, crucial to having health impact, translation into effective clinical practice ("T2"), care delivery and public health ("TS"), and health policy ('T4"). In 2008 we started Tufts CTSl building on prior CTR resources, services, and educational programs, we purposely selected partners that would leverage and complement each other's special assets. Our 38 strategically- chosen partners Include 12 Tufts University schools/research centers, ten Tufts hospitals, three academic institutions (Brandeis University, Northeastern University, RAND Corporation), eight community-based organizations, and five industry partners, an outstanding and synergistic resources, opportunities, and education across the T1-T4 spectrum. Described in our application's four sections are four aims that build on this platform: AIM 1: Strengthen Tufts CTSl overall by: 1) organizing and leading its partners in their commitment to this shared home for CTR; 2) expanding efficient access for all partners to a full spectrum of high-quality resources in a way that promotes collaborative CTR across disciplines and institutionsjS) advancing the field of CTR through local and national leadership and development of novel methods;4) providing innovative and tai^eted education and training across the T1-4 spectmm. (Section I) AIM 2: Operationalize and implement the CTR home and its infra- stnjcture, sen/ices and programs, including its central office personnel, administrative and financial management systems, committees, and other necessary structures. (Section II) AIM 3: Sustain and grow innovative resources, services, and policies that support and promote collaborative, cross-disciplinary, full-spectrum translational research. (Section III) AIM 4: Develop and broaden the CTR workforce through education and training across the T1-T4 spectrum, with a specific focus on addressing translational gaps between bench to bedside and from bedside to widespread impact on health. (Section IV) RELEVANCE (See Instmctions): Tufts Clinical and Translational Science Institute uses the entire spectrum of clinical and translational research (CTR) to help meet the promise and the public's needs of biomedical science.This includes bench "to bedside ("Tl") translation and crucially for having health impact, translation into effective clinical practice ("T2"), care delivery and public health ("TS-), and health policy (¿T4").